Doctor-led medical distributor Enesi Australia has officially launched in the Australian market, bringing two advanced regenerative aesthetic technologies to local practitioners.
Enesi now holds exclusive national distribution rights for Resilielle Age Zero™ Exosomes, the world’s highest-tested topical exosomes derived from Wharton’s Jelly mesenchymal stem cells. Verified by Harvard Medical School TEM analysis and produced under FDA-compliant cGMP standards, these frozen (not freeze-dried) exosomes maintain full bioactivity to support enhanced recovery and improved outcomes following microneedling, laser and energy-based procedures.
The company is also introducing the Juvasonic™ Device, a precision nano-vibration delivery system designed to increase serum and exosome penetration through gentle micro-disruption of the stratum corneum. The device offers a consistent, comfortable and non-invasive approach suitable for clinical and medispa environments.
Driven by scientific integrity and ethical practice, Enesi aims to bridge biotechnology and aesthetic medicine, equipping Australian clinicians with evidence-based regenerative tools that deliver measurable results.
For more information: www.enesi.com.au
